Dublin, Feb. 26, 2024 (GLOBE NEWSWIRE) -- The 'Next Generation Cancer Diagnostics Market Report: Trends, Forecast and Competitive Analysis to 2030' report has been added to ResearchAndMarkets.com's offering.The global next generation cancer diagnostics market is expected to reach an estimated $17.9 billion by 2030 with a CAGR of 11.0% from 2024 to 2030.The future of the global next generation cancer diagnostics market looks promising with opportunities in the biomarker development, CTC analysis, proteomic analysis, epigenetic analysis, and genetic analysis markets.

都柏林，2024年2月26日（环球通讯社）--“下一代癌症诊断市场报告：趋势，ResearchAndMarkets.com的产品中增加了2030年报告的预测和竞争分析。到2030年，全球下一代癌症诊断市场预计将达到179亿美元，2024年至2030年的复合年增长率为11.0%。全球下一代癌症诊断市场的未来前景看好，生物标志物开发，CTC分析，蛋白质组学分析，表观遗传分析和遗传分析市场。

The major drivers for this market are increasing prevalence of oncology disorders, requirement for effective prognosis and early detection of different types of cancer, as well as, growing efforts by important stakeholders to create novel approaches to address the growing need for effective diagnostics.Companies in the market compete on the basis of product quality offered.

该市场的主要驱动因素是肿瘤学疾病的患病率增加，对有效预后和早期发现不同类型癌症的要求，以及重要利益相关者越来越多地努力创造新的方法来满足对有效诊断的日益增长的需求。市场上的公司根据提供的产品质量进行竞争。

Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies next generation cancer diagnostics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base.

该市场的主要参与者专注于扩大其制造设施、研发投资、基础设施开发以及利用整个价值链的整合机会。通过这些策略，下一代癌症诊断公司可以满足不断增长的需求，确保竞争效率，开发创新产品和技术，降低生产成本，扩大客户群。

Next Generation Cancer Diagnostics Market Insights Therapeutic monitoring will remain the largest segment over the forecast period due to the growing use of immunotherapies and targeted treatments in the treatment of cancer has increased the demand for efficient therapeutic monitoring.North America will remain the largest region over the forecast period due to the existence of a solid healthcare system and strong focus on cancer.

下一代癌症诊断市场见解在预测期内，由于免疫疗法和靶向治疗在癌症治疗中的使用日益增加，治疗监测将保持最大的细分市场，这增加了对有效治疗监测的需求。由于存在可靠的医疗保健，北美将在预测期内保持最大的地区系统和强烈关注癌症。